Pitch and Partner 2016

You’ve discovered a promising new orphan drug candidate, what next?

In Orphan Drug Congress, Partnering & Investment by Freya Smale

You’ve discovered a promising new orphan drug candidate, what next?

I just read about how Katharine Sepp and Joost Schulte effectively found the right partners to help them develop and raise funds for a drug that protects brain cells from accelerated aging that occurs in disorders such as Huntington and Parkinson’s diseases.

  • Getting external validation first by getting an Orphan Drug Designation from the FDA
  • Collaborated with a regulatory consultant
  • Developed connections that worked on the same disease area; as far reaching and diverse as connections from Germany to Australia to the Netherlands

Read more about the story here >

You can do all of the above all by yourself or you can leverage the World Orphan Drug Congress USA’s Pitch & Partner session where scientists with promising new drugs, medical device or pathways get a chance to present their discovery to pharma, funding agencies, VCs and other investors.

The World Orphan Drug Congress USA from April 21-22, 2016 with pre-conference workshops on April 20th will be held in Washington DC.

The Pitch & Partner Session is a dedicated 2-day stream on April 21-22. If you’re interested call Shahariar Zaman today at 646 619 1788 or email him at zaman.shahariar@terrapinn.com

Slots are on a first come, first serve basis so call now to get your preferred slot. Check out the 2015 Pitch & Partner agenda here >

The production of World Orphan Drug Congress USA 2016 is well underway. Download the sponsorship prospectus to see how you can get involved.